Beijing chose instead to promote its own pharmaceutical firms, first in rolling out a more traditional but less effective Covid vaccine, and later, in the pursuit of a homegrown mRNA, or messenger RNA, vaccine.

Source: https://www.nytimes.com/2023/03/22/business/china-mrna-covid-vaccine.html

Moderna’s ambitions in messenger RNA technology include therapies that do their editing work inside the patient.

Source: https://medcitynews.com/2023/02/moderna-signs-on-a-new-partner-in-quest-for-in-vivo-mrna-gene-editing/

We are very encouraged by last year's base business growth and continue to see strong demand for both CleanCap reagents and our messenger RNA GMP manufacturing services and mRNA constructs.

Source: https://seekingalpha.com/article/4580939-maravai-lifesciences-holdings-inc-mrvi-q4-2022-earnings-call-transcript?source=feed_all_articles